Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin

BACKGROUND: The importance of the reduction in hepatitis C virus (HCV) RNA levels 4 and 12 weeks after starting peginterferon (PEG-IFN) and ribavirin combination therapy has been reported to predict a sustained virologic response (SVR) in patients infected with HCV genotype 1. We conducted a multice...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyoda, Hidenori, Kumada, Takashi, Shimada, Noritomo, Takaguchi, Koichi, Ide, Tatsuya, Sata, Michio, Ginba, Hiroyuki, Matsuyama, Kazuhiro, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573976/
https://www.ncbi.nlm.nih.gov/pubmed/23181537
http://dx.doi.org/10.1186/1471-2334-12-324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573976/
https://www.ncbi.nlm.nih.gov/pubmed/23181537
http://dx.doi.org/10.1186/1471-2334-12-324

Ejemplares similares